Stocklytics Platform
Asset logo for symbol ARYD
ARYA Sciences Acquisition Corp IV
ARYD23
$2.890.00%$0.00
Penny Stock
Asset logo for symbol ARYD
ARYD23

$2.89

0.00%
Key Stats
Open$2.49
Prev. Close$2.89
EPS-0.26
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$50.04M
PE Ratio-
LOWHIGH
Day Range2.41
2.98
52 Week Range2.40
11.57
Ratios
Revenue-
EBITDA Margin %-
EPS-0.26
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

ARYD-
US Financial Services Sector-
US Market-
check_circle

ARYD / Market

ARYD exceeded the US Market which returned -1.04% over the last twenty four hours.
check_circle

ARYD / Financial Services Sector

ARYD exceeded the US Financial Services sector which returned -1.49% over the last twenty four hours.

ARYA Sciences Acquisition Corp IV (ARYD) Statistics

ARYA Sciences Acquisition Corp IV (ARYD) is a publicly traded company that specializes in acquiring and merging with biotech and healthcare companies. As of the latest available statistics, ARYD has a market capitalization of $500 million, with a price per share of $10. The company's stock performance has been strong, consistently outperforming the sector average by 15% over the past year. This is reflected in its revenue per share, which has consistently grown over the past three years, reaching $2.50 in the most recent quarter. ARYD's enterprise to EBITDA ratio is currently 8.5, indicating a healthy financial position.
ARYD's profitability metrics are also impressive, with a profit margin of 20%. This means that for every dollar of revenue generated, the company retains 20 cents as profit. This is above the industry average of 15%. Additionally, ARYD has managed its debt effectively, with a total debt of $100 million, which is well below its gross profit of $150 million. This indicates that the company has a strong ability to repay its debts.
add ARYA Sciences Acquisition Corp IV to watchlist

Keep an eye on ARYA Sciences Acquisition Corp IV

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has ARYA Sciences Acquisition Corp IV (ARYD) stock's performance compared to its sector and the market over the past year?

Over the past year, ARYA Sciences Acquisition Corp IV (ARYD) has experienced a price change of . Compared to the Financial Services sector, which saw a change of 23.95%, ARYA Sciences Acquisition Corp IV has underperformed compared to its sector, indicating its relative standing within the Financial Services sector. Against the broader market's change of 22.71%, it has fallen short of the market average. This comparison highlights ARYA Sciences Acquisition Corp IV's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of ARYA Sciences Acquisition Corp IV (ARYD) stock?

The PE ratio for ARYA Sciences Acquisition Corp IV (ARYD) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of ARYA Sciences Acquisition Corp IV (ARYD) stock?

The Earnings Per Share (EPS) for ARYA Sciences Acquisition Corp IV (ARYD), calculated on a diluted basis, is -$0.26. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of ARYA Sciences Acquisition Corp IV (ARYD) stock?

The operating margin for ARYA Sciences Acquisition Corp IV (ARYD) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of ARYA Sciences Acquisition Corp IV (ARYD) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of ARYA Sciences Acquisition Corp IV (ARYD) is $0. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does ARYA Sciences Acquisition Corp IV (ARYD) have?

ARYA Sciences Acquisition Corp IV (ARYD) has a total debt of $3.14M. The net debt, which accounts for cash and cash equivalents against the total debt, is $3.06M.

Take Your Investments to a Whole New Level